Presentation is loading. Please wait.

Presentation is loading. Please wait.

CHAPTER 21 Cholinergic-Blocking Drugs

Similar presentations


Presentation on theme: "CHAPTER 21 Cholinergic-Blocking Drugs"— Presentation transcript:

1 CHAPTER 21 Cholinergic-Blocking Drugs
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.

2 Definition Drugs that block or inhibit the actions of acetylcholine (ACh) in the parasympathetic nervous system (PSNS) Also known as anticholinergics

3 Mechanism of Action Competitive antagonists Compete with ACh
Block ACh at muscarinic receptors in the PSNS As a result, ACh is unable to bind to the receptor site and cause a cholinergic effect Once these drugs bind to receptors, they inhibit nerve transmission at these receptors

4

5 Chemical Class Natural Synthetic/Semisynthetic
atropine benztropine clidinium belladonna dicyclomine glycopyrrolate hyoscyamine homatropine ipratropium scopolamine isopropamide methscopolamine oxybutynin propantheline tolterodine trihexyphenidyl Many Others

6 Drug Effects Cardiovascular CNS Small doses: decrease heart rate
Large doses: increase heart rate CNS Small doses: decrease muscle rigidity and tremors Large doses: drowsiness, disorientation, hallucinations

7 Drug Effects (cont’d) Eye Gastrointestinal Dilated pupils (mydriasis)
Decreased accommodation caused by paralysis of ciliary muscles (cycloplegia) Gastrointestinal Relax smooth muscle tone of GI tract Decrease intestinal and gastric secretions Decrease motility and peristalsis

8 Drug Effects (cont’d) Genitourinary Glandular Relaxed detrusor muscle
Increased constriction of internal sphincter Result: urinary retention Glandular Decreased bronchial secretions, salivation, sweating

9 Drug Effects (cont’d) Respiratory Decreased bronchial secretions
Dilated bronchial airways

10 Indications: CNS Decreased muscle rigidity and muscle tremors
Parkinson’s disease Drug-induced extrapyramidal reactions

11 Indications: Cardiovascular
Affect the heart’s conduction system Low doses: slow the heart rate High doses: block inhibitory vagal effects on SA and AV node pacemaker cells Results in increased heart rate

12 Indications: Cardiovascular (cont’d)
Atropine Used primarily for cardiovascular disorders Diagnosis of sinus node dysfunction Symptomatic second-degree heart block Severe sinus bradycardia with hemodynamic compromise (advanced life support)

13 Indications: Respiratory
Blocking the cholinergic stimulation of the PSNS allows unopposed action of the SNS Results Decreased secretions from nose, mouth, pharynx, bronchi Relaxed smooth muscles in bronchi and bronchioles Decreased airway resistance Bronchodilation

14 Indications: Respiratory (cont’d)
Respiratory drugs are used to treat: Exercise-induced bronchospasms Chronic bronchitis Asthma Chronic obstructive pulmonary disease

15 Indications: Gastrointestinal
PSNS controls gastric secretions and smooth muscles that produce gastric motility Blockade of PSNS results in: Decreased secretions Relaxation of smooth muscle Decreased GI motility and peristalsis

16 Indications: Gastrointestinal (cont’d)
Gastrointestinal drugs are used to treat: Irritable bowel disease GI hypersecretory states

17 Indications: Genitourinary
Reflex neurogenic bladder Incontinence

18 Indications Acute pancreatitis: reduces gastric and pancreatic secretions Preoperatively: reduces salivary secretions

19 Adverse Effects Body System Adverse Effects
Cardiovascular Increased heart rate, dysrhythmias CNS CNS excitation, restlessness, irritability, disorientation, hallucinations, delirium

20 Adverse Effects (cont’d)
Body System Adverse Effects Eye Dilated pupils, decreased visual accommodation, increased intraocular pressure Gastrointestinal Decreased salivation, decreased gastric secretions, decreased motility

21 Adverse Effects (cont’d)
Body System Adverse Effects Genitourinary Urinary retention Glandular Decreased sweating Respiratory Decreased bronchial secretions

22 Interactions Antihistamines, phenothiazines, tricyclic antidepressants, MAOIs When given with cholinergic blocking drugs, cause additive cholinergic effects, resulting in increased effects

23 Nursing Implications Keep in mind that these drugs block the action of ACh in the PSNS Assess for allergies, presence of BPH, glaucoma, tachycardia, MI, HF, hiatal hernia, and GI or GU obstruction Perform baseline assessment of vital signs and systems overview

24 Nursing Implications (cont’d)
Medications should be taken exactly as prescribed to have the maximum therapeutic effect Overdosing can cause life-threatening problems Blurred vision may cause problems with driving or operating machinery

25 Nursing Implications (cont’d)
Patients may experience sensitivity to light and may want to wear dark glasses or sunglasses When giving ophthalmic solutions, apply pressure to the inner canthus to prevent systemic absorption

26 Nursing Implications (cont’d)
Dry mouth may occur; can be handled by chewing gum, frequent mouth care, and hard candy Check with physician before taking any other medication, including over-the-counter medications Antidote for atropine overdose is physostigmine

27 Nursing Implications (cont’d)
Anticholinergics taken by the elderly patient may lead to higher risk for heatstroke because of the effects on heat-regulating mechanisms Teach patients to limit physical exertion and avoid high temperatures and strenuous exercise Emphasize the importance of adequate fluid and salt intake

28 Nursing Implications (cont’d)
Patients should report the following symptoms to their physician: urinary hesitancy and/or retention, constipation, palpitations, tremors, confusion, sedation or amnesia, excessive dry mouth (especially if they have chronic lung infections or disease), or fever

29 Nursing Implications (cont’d)
Monitor for therapeutic effects For patients with Parkinson’s disease: fewer tremors and decreased salivation and drooling For patients with urologic problems: improved urinary patterns, less hypermotility, increased time between voiding Monitor for adverse effects


Download ppt "CHAPTER 21 Cholinergic-Blocking Drugs"

Similar presentations


Ads by Google